Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don’t agree with this.
Charles and Chandra ran away with the stolen goodies Clone 3, clone 7 and AI platform
I can guarantee you Charles got Clone 3/7 whatever it is out and Chandra followed. The safe harbor statements protect them from anything stated in a PR at the time it’s issued. Things change. Just because they were hopeful of something in a year or two old PR and stated specific things at the time, doesn’t mean when things don’t pan out or go south that they are liable after the fact for defrauding. You’d have to prove purposeful intent to defraud, which is basically impossible. Every PR has those safe harbor statements at the end to protect the company should things not go as planned at the time of the PR.
Just from the recent PR:
“Safe Harbor Statement: This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Enzolytics, Inc. from time to time in its periodic reports filed with the SEC.
While Enzolytics, Inc. believes that the forward-looking statements and underlying assumptions contained therein are reasonable, any of the assumptions could be inaccurate, including, but not limited to, the ability of Enzolytics to identify acquisition targets and formulate a business strategy for implementation. Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate.
Such forward-looking statements are based on current expectations. They involve inherent risks and uncertainties, including factors that could delay, divert or change any of the statements made, and cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. These forward-looking statements are made as of the date of this press release.
Those are your educated guesses, as were mine, nothing there was 'for sure'. I never saw anything about a project cancellation, just a delay.
All that being said, you could be exactly right, but they can't list true assets until a monetary value is assigned, and research product is not that. They could estimate. Getting a true FINRA motion ready, I would not be listing BGEN assets either, the ink isn't even fully dry on this.
I hope your wrong, admit you may be right, but we're back to wait-n-see again, and that is worth it, just to see what gives over the next 60 days. Nothing good, I'm out, if something pushes truly up, I'll have new evaluations to do.
GLTA
For once Archilles, we are in full agreement. 100% correct.
Charles did the smart thing after all. Some of us questioned for months why he was still allowing the SAGA deal to go through with all their major pending issues, putting their Clone 3 and other assets at risk. And reputations at risk with SAGA being shady, delisted and the lawsuit.
Going to speculate that Charles wanted this thing nixed and Harry refused to void the ENZC / SAGA deal and that’s the final straw that led to the falling out and change of control with Charles and Chandra both leaving to take their tech elsewhere. Makes perfect sense with how today’s PR was worded. Charles and Chandra left, taking the tech out of BGEN, leading to the change of control in ENZC and then this new amended SAGA deal without BGEN being involved. Why was BGEN not involved and the deal was cut from $450 approx in half? Bc there’s no assets left in BGEN clearly so it was not worth anything to be still part of the deal. I would bet anything this is how it played out. Just put two and two together from what we know without any bias and it makes perfect sense.
Charles did the smart thing to get his assets out of this and Chandra was smart to follow.
It sounded like BGEN was returned to ENZC as an an empty shell because Charles and Chandra were officially gone according to the latest ENZC PR. Charles and Chandra left ENZC and took the Clone 3 , clone 7 and the AI platform with them, respectively. Charles and Chandra opened up their new companies which have nothing to do with BGEN nor EnZC any more
SAGA is still delisted and worthless to ENZC shareholders in terms of dividend shares.
Charles and Chandra ran away with the stolen goodies Clone 3, clone 7 and AI platform with them to found new companies
More reasons and incentives for ENZC shareholders to go after them
Clone7 would have been even more money.
Don't rush to judgement though, half of me suspects you are correct, assets are gone, but if that IS the case, then ENZC is guilty of defrauding the customers posting PR's and website statements, not to mention social media claims, that they owned Clone3, Clone7, ITV-1, the AI, all of it.
The website was back up yesterday, and I reread all of it. Might still be up now.
The agreement with SAGA was BGEN plus assets, the IP, etc... as under SAGA ownership, that being the case, CC and Chandra can't run off with anything, except some expertise in the AI design and troubleshooting.
Who really owns it is the legal question. Catropia's name on the patent application does not mean it's not owned by BGEN-now-ENZC.
This has to get clarified with hard evidence, fast. If they put out any public forum or Q&A to the shareholders, I'll make it a life mission to be there and grab-the-mike, so to speak. Maybe I can get Sharabura to grant the interview that Chandra canceled out on. His incentive would be, to clear the air, once and for all.
Yes, what they don't say is key, but it may not be that the goods are gone. This is where Achilles makes his best point. Either they still own those assets, or they are at risk of a major shareholder defrauding scheme, that safe-harbor waivers don't protect them from. Either they own it, or they've hung themselves badly. SAGA too.
$ENZC NEWS OUT TODAY 4/26, includes SAGA, BGEN and VIRO . Remember I post the links to data, NO IMO's
---
$ENZC News out today with SAGA. Definition of Novation "Novation refers to the process of substituting an existing contract with a replacement contract, where the contracting parties reach a consensus. One of the contracting parties in the original contract is replaced by an entirely new party that assumes the rights and obligations of the original party."
---
https://finance.yahoo.com/news/sagaliam-acquisition-corp-announces-novation-120000626.html?guce_referrer=aHR0cHM6Ly90LmNvLw&guce_referrer_sig=AQAAADFHcsh9wLllAx0AG-c48DZwQHRN7qYPPX7TEsIpag8GDFxMndrqqQ-yDM5PZxQgQpQC_NTZdsKbc3G_LwbrMS_4MXrF0k_P48KZpJONi22bF2yia0IXetmHu-GKEZdsz2bCeep19vBXh13wpZ0UO5aKjDvolYvWrZlTfjGLCymO&guccounter=2
There was no mention of any assets under BGEN. Don’t you think if there actually were those major assets back under ENZC, through BGEN, it would have been mentioned in the PR? It wasn’t mentioned bc they are gone with Charles and Chandra.
Put two and two together ffs. The filings just released show Charles and Chandra both officially gone. They even issued a supplemental change of control filing that verifies this fact. And Harry with full control with the preferred A voting shares. Harry is now fully in control of ENZC. Charles and Chandra and their assets officially out. Read the PR as well. All progress under VIRO is basically back to square one. Africa project was cancelled. We already knew that long ago. Not sure why that’s still a question.
Great conjecture and educated speculation too, from some smart folks. Yes, plenty of bitchin', but a lot of that was WELL DESERVED. Their messy corp board shakeup is hard evidence of that, no matter the outcome.
Wow, BGEN assets back to ENZC ?? May be the turnaround everyone should hope for, but I'd love to see corroborating evidence, not just a PR on it.
Can we determine, for certain, Clone3, Clone7 and the AI under Enzc is all back? And did they have a successful African testing result on IPV-1? Sounds like confidence in the least of the ENZC assets there under VIRO.
More must come. Might explain today's rise in pps.
Per the new otcmarkets filing, Chandra refused his position on April 12th. That’s the same day the press release was issued stating he had not yet accepted his new position within ENZC. So looks like he read that PR on the 12th and immediately notified them he was refusing it.
The filing also shows that Charles is out from ENZC.
Looks for sure like there was a major falling out and Charles and Chandra took their assets elsewhere. Harry is now in full control of ENZC as the filing clarifies that the Z trust holds the preferred A voting shares.
Harry is in full control with preferred voting shares. This was part of the filing just posted on otcmarkets. See below.
“Disclosure of Change in Control and Other Material Events:
1. A description of event(s) and relevant date(s) resulting in the Change in Control.1
There was a special meeting of the shareholders held on March 19, 2024 at which a new board was elected, resulting in a change of control of the company.
2. The name(s) of person(s) who acquired control and person(s) from whom control was assumed. For corporations or other business entities, please provide the name(s) of person(s) beneficially owning or controlling such corporations or entities.2
Harry Zhabilov, Dr. Lachezar Ivanov and Dr. Gaurav Chandra were elected as the new board of directors. Charles Cotropia was not reelected to the Board. Harry Zhabilov and Dr. Ivanov accepted their appointments. On April 12, 2024, Dr. Chandra refused his position. The board is Harry Zhabilov and Dr. Lachezar Ivanov.
3. The name(s) of person(s) that participated in, assisted in, organized, or brokered the transaction between the purchaser and seller, resulting in the Change in Control (if applicable).
The Series A Preferred Shares have voting control of the entity. That has not changed. Those Series A holders are Felizian Paul and Zhabilov Trust (control person Diana Zhabilov). All Series A voted were present and voted in favor of the change in control.”
They just clarified a lot by what they didn’t say. You can tell by now that when these guys put out a PR but specifically don’t mention something, it’s bc it’s bad.
The deals for half, so the SAGA shares that will be handed out for the dividend after all will now be half what they were (bad enough before at 450 mil) and that are now worthless because it isn’t even tradeable.
The PR is glaring it what it didn’t say, that BGEN came back but with no mention of any assets. That’s bc they are gone. Charles and Chandra are 100% gone, removed per the ENZC filings posted yesterday by Timing and took their assets from BGEN with them. If anything of value was still under BGEN, they 100% would have just mentioned it in this sad attempt at a pump PR. The fact they left it vague about what was coming back under BGEN tells that much.
And they verified all progress and agreements are back to square one with what is under VIRO. Welcome to 2020 all over again, without Clone 3.
4 years of nonsense bitching, lies and complaining about ENZC. And yet ENZC and management continues to try make things right…
Just my initial thoughts on this new deal. They might be a bit rambling.
1. Viro goes to saga by itself for 29million shares(assuming $10 each value). If so, how much of those goes to commons?
2. Bgen goes back to ENZC. Does this include any of the IP? Will team CCC come back to finish their projects?
3. Does Harry still have the control block shares in ENZC? Was CCC even involved in this updated deal with SAGA?
4. If they are updating the deal, doesn't that imply the original BCA hasn't been completed?
5. Zero mention of any ITV1 trials. What the hell happened to those?
From the news: "A novation is an agreement made between two contracting parties to allow for the substitution of a new party for an existing one."
I LIKE THE WHOLE DEAL AL LOT BETTER!!
Well...
This clears up absolutely nothing.
Bgen is no longer part of the BCA?
I have no idea what is going on.
https://finance.yahoo.com/news/sagaliam-acquisition-corp-announces-novation-120000626.html
I got rid of the constant harassment by clicking on the button to ignore D***89.
That’s a new one. Calling a post misleading bc he linked the actual company otc filings lmao. Unreal.
Yep. That's what I'm trying to do.
Thanks for posting a link. So helpful. Doesn’t prove a damn thing since current management is dishonest. Let’s dig deeper and not mislead…
And… why do you care…
Wow. Where are the analytics! You seriously believe this filing is accurate and honest? Sheesh
It's funny that James Zimbler is not mentioned in the annual report. I know he is part of the lawsuits. Is he no longer part of Enzolytics, Inc.? Did the new CEO finally fix that glitch with payroll and get the problem resolved?
Why are you here or will you be one of the ones selling ? GLTA
If you still believe in *holding* this *investment* after today's filing, you're clinically stupid lol
Yea…… huge sell off coming tomorrow!
I was using page 25 showing they hold thoses shares just that they have been removed as officers of the company. If they had converted and sold off we should have had a filing of them doing so. Thye at least didn't sell according to this thru Dec 2023 and up to March 2024 which show removal from office not shares that can be converted to common. Now we need the July filings to see if they still remain on filings as owners of more than the 5% and still have a stake in ENZOLYTICS. If they haven't sold of shares then that is showing they still think value is here of some sort.
So what is your overall take on this filing. I am seeing that the B series are still outstanding ?
When was the dividend anything other than SAGA shares? No one disputed that. So it is an absolute.
Yep Charles , Chandra and Joseph C all REMOVED, right on PAGE 25, with this March 2024 dates , REMOVED
https://www.otcmarkets.com/otcapi/company/financial-report/398912/content
--
Now look for OTC PROFILE page to be updated with this being out and another updated Attorney Letter to get back to Pink Current.
-
Charles S.
Cotropia
CEO/Director (removed on
3-25-2024)
Heath, Texas 68,143,334 Series B 15.39
---
Joseph
Cotropia
CSO (removed on 3-25-
2024)
College
Station, Texas
68,143,334 Series B 15.39
===
Gaurav
Chandra
COO (Removed on March
25, 2024)
Cape Town,
South Africa
68,143,332 Series B 15.39
According to the company it was. And that includes a life long lawyer who was with them at the time they completed it. So I think it’s safe to say that it was. Highly doubt all these guys are continuing forward with all the scrutiny on it if they knew it was illegal from the start. Especially not Charles as a life long lawyer. That tells me that whatever fine print they tossed into it made it technically legal. Whether it met the nasdaq requirements is moot now.
You're speaking in absolutes.
Was the saga deal legal?
Glad there’s now finally confirmation for those still unwilling to believe that Charles and Chandra are both officially gone.
You were never getting money. You were getting SAGA shares. Which it appears you’ll still be getting.
All these subjective IMO's out there , is nonsense .. go with the facts and disclosures and remember I post the links for one to check.
--
New Change of Control filed today . CC and Chandra are not listed in accepting any role or for that mater Joe C.
https://www.otcmarkets.com/otcapi/company/financial-report/398927/content
--
Annual is out now today also filed. remember this is for year end 2023 , HOWEVER, NOTE page 25 shows for SURE CC is out, Chandra is out , Joe C is out . Also all those folks on the share disclosure do not (any longer show any COMMON SHARES !!) on preferred B .
https://www.otcmarkets.com/otcapi/company/financial-report/398912/content
ENZC said all kinds of shit but you cant pick and choose only the things that fit your story.Even if you only get a partial win or return you can write the total off as total tax loss.
450 million was the exchange as I remember.
If that’s the case then Yes. Show me the money!
No they don’t, it was sold to SAGA under the subs in the competed deal. Which even the new ENZC ceo is telling you in a PR was completed bc they are contacting FINRA to commence with the distribution of the dividend shares. The now worthless SAGA dividend shares, but none the less, they’ll be handing them out.
And like some of us repeatedly warned last summer, they told all shareholders at that time, well in advance, there would be “no assets, no operations” left in ENZC after the completion of the sale.
Here we are now, “no assets” left under ENZC and people are screaming to the sky for lawsuits. Get real people.
All the AI used to find the immutable virus scape was done 3 years ago. ENZC owns that.
Followers
|
1245
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
200034
|
Created
|
01/07/10
|
Type
|
Free
|
Moderators Homebrew Timing101 archilles SeniorApollo |
Independent Valuation Report Pre Clinical Studies
Investments
___________________________________________________________________________________
Press Release July 20-2021
Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc.
for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies
https://www.creative-biolabs.com/
https://finance.yahoo.com/news/enzolytics-announces-signing-letter-intent-113000339.htm
________________________________________
Press release July 21-2021
Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and
Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics
https://www.lonza.com/
https://www.bloomberg.com/press-releases/2021-07-21/enzolytics-and-lonza-bioscience-combine-technologies-to-fast-track-development-and-production-of-anti-hiv-and-anti-sar
_________________________________________
July 22 INTERVIEW
with
James Hicks, Charles Cotropia and Gurav Chandra
http://www.youtube.com/watch?v=mdljO9VLgj0
______________________________________________________________
COLLEGE STATION, TX August 25, 2021
Important Excerpt from this news progress update.
>>>>>><<<<<<
"The monoclonal antibodies being produced by Enzolytics against the CoronaVirus target 19 conserved immutable sites on the virus, sites which the Company has now confirmed are conserved sites not only on the initial virus strains but also existing in the Delta and Lambda variants, as well as in the Alpha, Beta and Gamma variants."
Enzolytics Inc. and Samsung Biologics Announce
Development and Manufacturing Agreement for Anti-
HIV and Anti-SARS-CoV-2
Important Excerpt from this news progress update.
>>>>>><<<<<<
"Samsung Biologics (KRX: 207940. K.S.), a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, announced the signing of a strategic CDMO partnership agreement."_______
2000 North Central Expressway
Plano, TX 75074
972-292-9414
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |